Zivo Bioscience, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Zivo Bioscience, Inc. quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2022 to Q1 2024.
  • Zivo Bioscience, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.